<div id="readability-page-1"><p><span>UnitedHealth Group (NYSE:UNH - Get Free Report)</span> had its price objective increased by equities research analysts at Mizuho  from $600.00 to $650.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an &#34;outperform&#34; rating on the healthcare conglomerate's stock. Mizuho's price target would suggest a potential upside of 17.37% from the company's current price.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>3 Health Insurance Stocks Holding Green in Market Turmoil</li></ul><p>Several other equities analysts also recently issued reports on the stock. KeyCorp  restated an &#34;overweight&#34; rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a &#34;buy&#34; rating for the company in a research note on Monday, January 6th. StockNews.com raised UnitedHealth Group from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Thursday, January 23rd. Hsbc Global Res upgraded UnitedHealth Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Friday, January 10th. Finally, Cantor Fitzgerald  reiterated an &#34;overweight&#34; rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Twenty-one research analysts have rated the stock with a buy rating and two have issued  a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group  has a consensus rating of &#34;Buy&#34; and an average target price of $630.35.</p><p><b>Check Out Our Latest Research Report on UnitedHealth Group</b></p><h2>UnitedHealth Group Price Performance</h2><ul><li>MarketBeat Week in Review – 02/24 - 02/28</li></ul><p>Shares of UNH stock opened at $553.81 on Wednesday. UnitedHealth Group has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market cap of $506.57 billion, a P/E ratio of 35.73, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock's 50-day moving average is $509.40 and its 200 day moving average is $541.42. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the firm earned $5.83 earnings per share. UnitedHealth Group's revenue was up 6.8% compared to the same quarter last year.  Research analysts predict that  UnitedHealth Group will post 29.54 earnings per share for the current fiscal year. </p><h2>Insiders Place Their Bets</h2><ul><li>3 Beaten Down Healthcare Stocks Recovering in 2025</li></ul><p>In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this link. 0.33% of the stock is owned by company insiders. </p><h2>Institutional Inflows and Outflows</h2><p>Institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC boosted its stake in  UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after buying an additional 319,515 shares during the last quarter.  Capital International Investors increased its position in  UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the last quarter.  Norges Bank acquired a new position in  UnitedHealth Group in the 4th quarter valued at about $6,375,744,000.  Northern Trust Corp increased its holdings in shares of  UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter.  Finally, Franklin Resources Inc. lifted its holdings in  UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after acquiring an additional 861,854 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors. </p><h2>About UnitedHealth Group</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>What is a Secondary Public Offering? What Investors Need to Know</li><li>Oil Prices Are Tanking—These 3 Plays Could Fuel Your Gains</li><li>Insider Buying Explained: What Investors Need to Know</li><li>Top 3 S&amp;P 500 Winners in a Losing Market</li><li>Why Invest in 5G? How to Invest in 5G Stocks  </li><li>General Motors: When Good News Isn’t Good Enough</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Mizuho has raised its price target for UnitedHealth Group (NYSE:UNH) from $600.00 to $650.00, maintaining an "outperform" rating. This new target suggests a potential upside of 17.37% from the current price. Other analysts have also issued positive ratings, with a consensus rating of "Buy" and an average target price of $630.35. UnitedHealth Group reported earnings of $6.81 per share, exceeding estimates, and has shown a revenue increase of 6.8% year-over-year. The stock opened at $553.81, with a market cap of $506.57 billion.</p>

UnitedHealth Group (NYSE:UNH) Given New $650.00 Price Target at Mizuho